Sridhar G. Prasad
CIK: 0002038368
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Prasad Sridhar G.
Prasad Sridhar G. (SEC CIK 0002038368) files insider reports with the SEC as Director of Drugs Made In America Acquisition II Corp. (DMII) and Director of Drugs Made In America Acquisition Corp. (DMAA).
Signal8 holds 4 ownership filings by Prasad Sridhar G. (2 Form 3, 2 Form 4), filed between Jan 10, 2025 and Oct 1, 2025. Those filings report 2 transactions, from Jan 29, 2025 to Sep 26, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Prasad Sridhar G.'s filings is in FORT LAUDERDALE, FL.
Recent filings by Prasad Sridhar G.
Other insiders filing for Drugs Made In America Acquisition II Corp. (DMII)
- Do Catherine, Director
- Shulgan Myron W., Director
- Worman Glenn C., CFO
- Stockwell Lynn, CEO and Exe. Chair of Board
- Drugs Made In America Acquisition II LLC, 10% Owner